Cabozantinib and dastinib exert anti-tumor activity in alveolar soft part sarcoma.

about

Cabozantinib and dastinib exert anti-tumor activity in alveolar soft part sarcoma.

Item

http://www.wikidata.org/entity/Q42363585

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Cabozantinib and dastinib exert anti-tumor activity in alveolar soft part sarcoma.

@en

Cabozantinib and dastinib exert anti-tumor activity in alveolar soft part sarcoma.

@nl

type

Item

label

Cabozantinib and dastinib exert anti-tumor activity in alveolar soft part sarcoma.

@en

Cabozantinib and dastinib exert anti-tumor activity in alveolar soft part sarcoma.

@nl

prefLabel

Cabozantinib and dastinib exert anti-tumor activity in alveolar soft part sarcoma.

@en

Cabozantinib and dastinib exert anti-tumor activity in alveolar soft part sarcoma.

@nl

P1476

Cabozantinib and dastinib exert anti-tumor activity in alveolar soft part sarcoma.

@en

P2093

Daisuke Kubota

http://www.w3.org/2001/XMLSchema#string

Eisuke Kobayashi

http://www.w3.org/2001/XMLSchema#string

Kazuo Kaneko

http://www.w3.org/2001/XMLSchema#string

Keisuke Akaike

http://www.w3.org/2001/XMLSchema#string

Kenta Mukaihara

http://www.w3.org/2001/XMLSchema#string

Masaki Hosoya

http://www.w3.org/2001/XMLSchema#string

Shingo Sato

http://www.w3.org/2001/XMLSchema#string

Shinji Kohsaka

http://www.w3.org/2001/XMLSchema#string

Taketo Okubo

http://www.w3.org/2001/XMLSchema#string

Takuo Hayashi

http://www.w3.org/2001/XMLSchema#string

P2860

The protein tyrosine kinase family of the human genome

A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo

The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25

Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

Gene expression profiling of alveolar soft-part sarcoma (ASPS).

Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor-associated tumors: results of a multicenter phase 2 trial.

The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study.

Cellular processes of v-Src transformation revealed by gene profiling of primary cells--implications for human cancer.

P304

e0185321

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0185321

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kaoru Mogushi

Yoshiyuki Suehara

P577

2017-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28945796

http://www.w3.org/2001/XMLSchema#string

P932

5612696

http://www.w3.org/2001/XMLSchema#string